Ontology highlight
ABSTRACT: Background/aims
Anti-ganglionic nicotinic acetylcholine receptor (gAChR) antibodies are observed in autoimmune diseases, as well as in patients with autoimmune autonomic ganglionopathy. However, the genetic background of anti-gAChR antibodies is unclear. Here, we investigated HLA alleles in autoimmune hepatitis (AIH) patients with or without anti-gAChR antibodies.Methodology/principal findings
Genomic DNA from 260 patients with type-1 autoimmune hepatitis (AIH) were genotyped for HLA-A, B, DRB1, and DQB1 loci. Anti-gAChR antibodies in the sera form AIH patients were measured using the luciferase immunoprecipitation system, and examined allelic association in patients with or without anti-gAChR antibodies.Methodology/ methods
We detected anti-?3 or -?4 gAChR antibodies in 11.5% (30/260) of patients with AIH. Among AIH patients there was no significant association between HLA-A, B DQB1 alleles and the positivity for anti-gAChR antibodies. Whereas the HLA-DRB1*0403 allele showed a significantly increased frequency in AIH patients with anti-gAChR antibodies compared with those without anti-gAChR antibodies.Conclusions/significance
The frequency of the HLA-DRB1*0403 allele differed among Japanese patients with AIH according to the presence or absence of anti-gAChR antibodies. Our findings suggest that particular HLA class II molecules might control the development of anti-gAChR antibodies in the autoimmune response to gAChR.
SUBMITTER: Maeda Y
PROVIDER: S-EPMC4726510 | biostudies-literature | 2016
REPOSITORIES: biostudies-literature
Maeda Yasuhiro Y Migita Kiyoshi K Higuchi Osamu O Mukaino Akihiro A Furukawa Hiroshi H Komori Atsumasa A Nakamura Minoru M Hashimoto Satoru S Nagaoka Shinya S Abiru Seigo S Yatsuhashi Hiroshi H Matsuo Hidenori H Kawakami Atsushi A Yasunami Michio M Nakane Shunya S
PloS one 20160125 1
<h4>Background/aims</h4>Anti-ganglionic nicotinic acetylcholine receptor (gAChR) antibodies are observed in autoimmune diseases, as well as in patients with autoimmune autonomic ganglionopathy. However, the genetic background of anti-gAChR antibodies is unclear. Here, we investigated HLA alleles in autoimmune hepatitis (AIH) patients with or without anti-gAChR antibodies.<h4>Methodology/principal findings</h4>Genomic DNA from 260 patients with type-1 autoimmune hepatitis (AIH) were genotyped for ...[more]